BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 17444118)

  • 1. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
    Tuberculosis Research Committee
    Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [External quality assessment of drug susceptibility testing for Mycobacterium tuberculosis].
    Mitarai S; ;
    Kekkaku; 2006 Aug; 81(8):501-9. PubMed ID: 16972653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory, in 1997].
    Hirano K; Wada M; Abe C; Aoyagi T
    Kekkaku; 2001 Jun; 76(6):461-71. PubMed ID: 11494526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on quality control of drug susceptibility testing in the surveillance of drug resistance in tuberculosis in Henan].
    Xu J; Peng Y; Wang G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):724-6. PubMed ID: 11480073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug susceptibility test for Mycobacterium tuberculosis using non-radioactive substance, alpha-antigen].
    Shigeto E; Taska H
    Kekkaku; 1996 Mar; 71(3):245-52. PubMed ID: 8901226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of routine works and quality control in mycobacterial laboratory].
    Suzuki K; Higuchi T
    Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on prevalence of resistance to antituberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory].
    Kazumi Y; Hirano K; Abe C; Mori T; Aoki M; Aoyagi T
    Kekkaku; 1996 Mar; 71(3):267-76. PubMed ID: 8901229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proficiency analysis of drug susceptibility testing by national-level tuberculosis reference laboratories from 1995 to 2003.
    Bai GH; Kim SJ; Chang CL;
    J Clin Microbiol; 2007 Nov; 45(11):3626-30. PubMed ID: 17855570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EVALUATION STANDARD OF EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR DRUG SUSCEPTIBILITY TESTING OF MYCOBACTERIUM TUBERCULOSIS IN JAPANESE LABORATORIES: PROFICIENCY TESTING IN 2004-2010].
    Kekkaku; 2015 Apr; 90(4):481-90. PubMed ID: 26489152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan.
    Jou R; Chiang CY; Yu CY; Wu MH
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1142-7. PubMed ID: 19723405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistance) Study Group.
    Migliori GB; Ambrosetti M; Fattorini L; Penati V; Vaccarino P; Besozzi G; Ortona L; Saltini C; Orefici G; Moro ML; Lona E; Cassone A
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):940-6. PubMed ID: 11055761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.
    Fattorini L; Iona E; Cirillo D; Migliori GB; Orefici G; Aziz M; Wright A; Tafaj S; Baig B; Mulliqi G; Maungate S; Cuna Z; Al-Busaidy S; Al-Suwaidi Z; Ceyhan I
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):214-7. PubMed ID: 18230256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis isolates compared with the proportion method on solid media].
    Abe C; Aono A; Hirano K
    Kekkaku; 2001 Oct; 76(10):657-62. PubMed ID: 11712386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of mycobacteria growth indicator tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis isolates].
    Suzuki K; Tsuyuguchi K; Matsumoto H; Niimi A; Tanaka E; Murayama T; Amitani R; Kuze F
    Kekkaku; 1997 Apr; 72(4):187-92. PubMed ID: 9145648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-tuberculosis drug resistance in Japan and in the world].
    Abe C
    Kekkaku; 2001 Nov; 76(11):699-706. PubMed ID: 11766361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
    Kobayashi I; Abe C; Mitarai S
    Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.